Physician profile
Summer Stanton
NPI 1023505815
$4,150.97
in general payments reported to CMS, 2019-2025
37 companies · $1,143 in 2025
The $1,143 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $140 · 2022: $870 · 2023: $945 · 2024: $1,052 · 2025: $1,143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,140.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $411.35 | 2021-2025 | Lofric, Gentlecath Glide |
| Janssen Biotech, INC. | $398.22 | 2022-2025 | Erleada, Akeega |
| Abbvie INC. | $332.48 | 2021-2025 | |
| Accord Healthcare, INC. | $290.95 | 2022-2024 | |
| Teleflex LLC | $268.86 | 2022-2025 | Urolift, Barrigel |
| Urogen Pharma, INC. | $211.97 | 2023-2025 | Jelmyto |
| Pfizer INC. | $200.90 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $198.85 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Sumitomo Pharma America, INC. | $180.01 | 2023-2025 | Gemtesa, Orgovyx |
| Tolmar, INC. | $163.34 | 2023-2025 | Jatenzo, Eligard |
| Dendreon Pharmaceuticals LLC | $142.84 | 2022-2023 | Provenge |
| Ferring Pharmaceuticals INC. | $134.72 | 2024-2025 | Adstiladrin |
| Bayer Healthcare Pharmaceuticals INC. | $133.57 | 2022-2024 | |
| Astellas Pharma US INC | $117.89 | 2023-2025 | Xtandi, Myrbetriq |
| Myovant Sciences INC. | $98.26 | 2021-2022 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $95.60 | 2024-2025 | Lithovue, Spaceoar Vue System - 10ml |
| Verity Pharmaceuticals INC. | $78.24 | 2023-2024 | Trelstar |
| Procept Biorobotics Corporation | $73.50 | 2022-2024 | Aquabeam System |
| Coloplast Corp | $64.59 | 2023-2024 | Speedicath |
| Progenics Pharmaceuticals, INC. | $58.66 | 2023-2025 | Pylarify |
| Tolmar Pharmaceuticals, INC. | $51.84 | 2022 | |
| Urovant Sciences INC | $47.40 | 2021-2022 | |
| Antares Pharma, INC. | $41.69 | 2022-2024 | Xyosted |
| Axonics, INC. | $39.84 | 2023-2024 | Axonics |
| Convatec INC. | $37.76 | 2023 | |
| C. R. Bard, INC. & Subsidiaries | $33.96 | 2023-2025 | Purewick Female External Catheter, Bard Urinary Drainage Bag |
| Blue Earth Diagnostics | $32.74 | 2022 | |
| Becton, Dickinson and Company | $29.66 | 2024 | Bard Urinary Drainage Bag |
| Applied Medical Resources Corporation | $28.58 | 2023 | |
| Rochester Medical Corporation | $26.83 | 2022 | |
| Civco Medical Instruments | $22.72 | 2024 | |
| Endo USA, INC. | $21.95 | 2024 | Xiaflex |
| Immunitybio, INC. | $20.58 | 2024 | |
| Novartis Pharmaceuticals Corporation | $17.87 | 2025 | |
| Photocure INC | $15.90 | 2023 | Cysview |
| Amarin Pharma, INC. | $14.58 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Summer Stanton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.